Fatal pneumonitis after treatment with pegylated liposomal doxorubicin in a patient with metastatic breast cancer in complete remission

Medical Oncology

Volumn 29, Issue 3, 2012, Pages 1477-1478

  Mark, Michael ^a   Thürlimann, Beat ^a  

^a CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; C REACTIVE PROTEIN; CA 15-3 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; GEMCITABINE; METHOTREXATE; TAMOXIFEN;

ADJUVANT CHEMOTHERAPY; AGED; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HORMONAL THERAPY; HUMAN; LETTER; MASTECTOMY; PLEURA EFFUSION; PNEUMONIA; PRIORITY JOURNAL; REMISSION;

AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DOXORUBICIN; FATAL OUTCOME; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; NEOPLASM RECURRENCE, LOCAL; PLEURAL EFFUSION, MALIGNANT; POLYETHYLENE GLYCOLS; REMISSION INDUCTION;

EID: 84872826329     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-011-0002-1     Document Type: Letter

References (3)

1. Inaba K et al. Interstitial pneumonitis induced by pegylated liposomal doxorubicin in a patient with recurrent ovarian cancer. Med Oncol; 2011. doi:10.1007/s12032-011-9893-0.
2. Huober J, Schoch O, Templeton A, Spirig C, Thürlimann B. Interstitial pneumonitis after treatment with bevacizumab and pegylated liposomal doxorubicin in a patient with metastatic breast cancer. Chemotherapy. 2010;56(1):69-70.
3. Mirza MR, et al. A phaseII study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin. Gynecol Oncol. 2010;119(1): 26-31.